Showing results (121-130 of 1,289) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|September 22, 2015
Atrial fibrillation and chronic kidney disease: focus on rivaroxabanVivencio Barrios, José Luis GórrizJournal of Comparative Effectiveness Research|September 22, 2015
Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparisonElyse Swallow, Jinlin Song, Yong Yuan, et al.Journal of Comparative Effectiveness Research|August 15, 2015
IMPACCT Kids' Care: a real-world example of stakeholder involvement in comparative effectiveness researchSonja Likumahuwa-Ackman, Heather Angier, Aleksandra Sumic, et al.Journal of Comparative Effectiveness Research|August 15, 2015
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillationQinmei Xiong, Yee C Lau, Gregory Y H LipJournal of Comparative Effectiveness Research|August 15, 2015
Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectivenessJulia M Rothlisberger, Bruce OvbiageleJournal of Comparative Effectiveness Research|December 16, 2014
Assessing the long-term impact of public investments in comparative effectiveness research: conceptual framework and lessons learnedEugene C Rich, Dominick Esposito, Laura D Kimmey, et al.Journal of Comparative Effectiveness Research|January 8, 2015
Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS)Ronald C Chen, William R Carpenter, Mimi Kim, et al.Journal of Comparative Effectiveness Research|January 18, 2020
Biomedical conferences' author instructions rarely mention guidelines for reporting abstracts of trials and systematic reviewsLenko Saric, Svjetlana Dosenovic, Jakov Mihanovic, et al.Journal of Comparative Effectiveness Research|November 6, 2020
The cost-effectiveness of low-dose budesonide as a Step 2 treatment for pediatric asthma in ChinaXiaoling Wang, Honghao Fang, Kunling Shen, et al.Journal of Comparative Effectiveness Research|November 10, 2020
Assessing direct costs of treating metastatic triple-negative breast cancer in the USAKaren E Skinner, Amin Haiderali, Min Huang, et al.Pageof 129